BioWorld

Jan. 10, 2003

View Archived Issues

ZymoGenetics, Novo Agree On $11M IL-21 Collaboratio

Read More

Ribosomes Batting Telomerase In Lethal Bone Marrow Failure, Aging Process, Susceptibility To Cancer

Read More

Idenix Begins Phase III Study Of Telbivudine For Hepatitis B

Read More

Antigenics Proposes Public Offering Of 4.5 Million Shares

Read More

Correction

Read More

Other News To Note

Read More

Boehringer Ingelheim Alliance Marks First Big Deal For Sagres

Sagres Discovery Inc. is stepping into the somewhat public world of drug discovery, entering into a research collaboration with Boehringer Ingelheim International GmbH to identify oncology drug targets. (BioWorld Today) Read More